Coherus Oncology, Inc.CHRSNASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 476 | 327↓31.4% | 211↓35.4% | 257↑21.9% | 267↑3.8% |
| Gross Profit | 438 | 269↓38.6% | 141↓47.6% | 98↓30.3% | 149↑52.1% |
| Operating Income | 156 | -264↓268.8% | -257↑2.6% | -203↑20.9% | -112↑45.0% |
| Net Income | 132 | -287↓317.1% | -292↓1.6% | -238↑18.5% | 29↑112.0% |
| EBITDA | 162 | -261↓261.1% | -256↑2.0% | -194↑24.1% | 61↑131.4% |
| EPS Diluted | 1.62 | -3.81↓335.2% | -3.76↑1.3% | -2.53↑32.7% | 0.25↑109.9% |